Genasys Inc. LRAD Cash Flow

Genasys inc. (LRAD)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10
Operating Activities:
Net income
1,482	2,359	2,784	420	-297	-1,015	-3,745	-1,136	-1,584	-1,747	-876	-1,556	-751	-1,714	-1,281	8,187	7,846	8,802	9,687	1,458	3,465	3,701	3,327	5,531	2,480	1,494	1,262	-428	880	1,047	1,462	580	-303	5,692	5,022	0	0	0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
822	832	824	769	706	624	483	396	284	180	153	127	132	143	167	189	215	233	238	245	242	236	209	187	166	150	146	0	0	0	-	-	-	-	-	-	-	-
Less: Net income from discontinued operations (Note 16)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	69	0	0	0
Net income from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,953	0	0	0
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	99	112	138	0	0	0
Provision for doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3	5	7	-4	-0	0	0	0	-	-	-	-	-	0	0	0
Warranty provision
29	44	85	56	37	14	6	-58	-169	-68	-70	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warranty provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	42	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory obsolescence
-	-	-	-	-	-	-	-	-	-	-	-28	-32	153	159	24	53	75	65	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warranty provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-43	-19	0	0	0	-	-	-	-	-	-	-	-
Warranty provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	153	74	0	0	0
Inventory obsolescence
136	181	142	200	219	186	171	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-118	-143	-177	39	-38	154	77	-133	185	-16	0	0	0
Share-based compensation
882	759	735	715	606	580	584	605	758	790	1,116	1,093	939	922	605	613	618	635	619	558	553	567	585	643	687	680	736	789	797	751	684	592	489	448	422	0	0	0
Deferred income taxes
282	459	570	255	63	-51	2,374	3,744	3,380	3,391	196	-78	352	-363	-188	-9,203	-9,196	-8,650	-8,339	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of operating lease right of use asset
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on impairment of patents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	86	28	35	36	41	20	13	31	22	0	0	0
Changes in operating assets and liabilities:
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	606	0	0	0
Accounts receivable, net
-922	-2,774	854	383	1,221	2,770	-3,149	3,794	2,051	4,199	2,272	-174	763	-462	1,292	-176	130	-545	-2,167	-1,022	-425	585	-678	2,587	415	-371	-559	-933	223	-466	424	-89	-257	756	910	0	0	0
Inventories, net
-1,247	-2,465	-756	1,208	3,081	3,634	1,648	-1	616	234	519	500	-114	30	-2	129	694	896	1,096	405	-839	-913	-655	-418	665	1,034	1,331	1,950	1,712	1,208	524	-495	-226	-2,666	-64	0	0	0
Prepaid expenses and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Prepaid expenses and other
371	16	-1,358	-101	-268	332	2,075	-29	-128	-165	147	37	48	67	29	-18	-45	-21	41	50	67	-43	-479	83	226	155	562	-269	-241	-291	-221	0	0	0	-	-	-	-
Other assets
-	-	-	-	-	-	60	13	-33	-226	-226	-226	-226	-187	-187	-187	-187	-187	-187	-148	-148	-148	-148	-187	-187	-187	-187	0	0	0	-	-	-	-	458	0	0	0
Accounts payable
708	-1,540	-2,211	-2,451	-2,157	-664	192	-308	333	828	537	343	-160	596	-129	53	405	-458	-126	748	-80	367	-765	-256	-121	-222	600	316	801	195	-44	125	-420	-1,637	75	0	0	0
Accrued and other liabilities
-3,552	-1,028	-67	-373	1,233	193	127	0	0	0	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warranty settlements
-	-	-	-	-	-	11	0	0	0	-	-	-	-	-	-	37	33	41	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warranty settlements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-31	26	10	0	0	0	-	-	-	-	-	-	-	-
Warranty settlements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-44	-47	0	0	0
Accrued and other liabilities
-	-	-	-	-	-	1,541	-568	-354	-135	-455	-190	-94	258	556	1,074	3,263	2,581	-526	520	-240	-57	2,942	2,096	475	273	205	94	436	376	-2,129	0	0	0	-	-	-	-
Accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,334	0	0	0
Net cash provided by operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,886	0	0	0
Net cash (used in) provided by operating activities of discontinued operations (Note 17)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	131	0	0	0
Net cash used in operating activities
8,612	13,167	9,855	1,511	-2,531	-5,595	1,251	496	1,174	-341	-666	0	0	0	-	-	-	-	-	-	-	0	-	6,453	2,755	1,730	1,755	777	2,147	2,553	194	1,445	2,513	5,896	4,017	0	0	0
Sales (purchases) of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investing Activities:
Purchases of marketable securities
4,190	4,260	4,495	5,003	4,836	4,121	4,920	3,812	3,536	3,110	2,908	0	0	0	-	-	-	-	4,299	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from maturities of marketable securities
3,882	3,833	4,228	5,479	5,105	4,045	5,190	3,894	3,488	3,534	2,961	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital expenditures
145	390	343	762	835	610	625	177	214	222	182	170	93	105	162	234	299	335	344	357	294	281	326	255	268	195	147	0	0	0	-	-	58	54	57	0	0	0
Patent costs paid
-	-	-	-	-	-	-	-	-	-	-	12	9	11	11	13	15	11	10	11	12	14	14	6	3	2	2	4	5	4	3	3	2	2	2	0	0	0
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	112	-681	-2,147	-4,654	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-452	-817	-610	-471	-752	-3,118	-2,787	-2,334	-2,505	202	-129	0	0	0	-	-	-	-	-	-	-	-	-	-262	-272	-197	-150	-186	-267	-279	-205	-174	-60	-57	-60	0	0	0
Financing Activities:
Proceeds from exercise of stock options
916	844	703	1,461	2,294	2,277	2,434	1,160	318	292	133	0	0	0	-	-	-	-	-	-	-	-	544	428	514	514	340	0	0	0	-	-	-	-	145	0	0	0
Repurchase of common stock
-	-	2,171	0	0	0	-	-	-	-	-	-	-	-	1,748	2,347	3,154	3,207	1,564	1,005	426	416	516	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
459	277	-1,484	-1,340	-1,380	-1,181	596	-62	-32	292	133	0	0	0	-	-	-	-	-	-	-	0	-	-48	265	414	340	0	0	0	-	-	-	-	4,492	0	0	0
Effect of foreign exchange rate on cash
-14	-25	-49	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash, cash equivalents, and restricted cash
8,605	12,603	7,710	-380	-4,747	-9,963	-997	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-618	-4,849	-2,236	-4,171	-4,507	-5,578	-3,416	615	2,003	8,089	6,142	2,748	1,947	1,945	696	1,898	2,293	-11	1,298	2,488	10,237	8,449	0	0	0
Change in unrealized loss on marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash investing and financing activities:
Change in unrealized gain (loss) on marketable securities
-0	17	20	22	18	-0	-7	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Initial measurement of operating lease right of use assets and liabilities
-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14	0	0	1	-38	-251	-251	-242	-152	60	72	164	222	0	0	0